Trajan Wealth LLC Has $23.37 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Trajan Wealth LLC increased its holdings in UnitedHealth Group by 14.3% during the 1st quarter, owning a total of 44,619 shares valued at approximately $23.37 million.
• Several hedge funds have modified their positions in UnitedHealth Group, with 87.86% of the stock now owned by institutional investors and hedge funds.
• UnitedHealth Group declared a quarterly dividend of $2.21 per share, representing an annualized dividend yield of 3.5%, an increase from the previous dividend of $2.10.

Trajan Wealth LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 14.3% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 44,619 shares of the healthcare conglomerate's stock after purchasing an additional 5,572 shares during the quarter. UnitedHealth Group comprises 1.3% of Trajan Wealth LLC's portfolio, making the stock its 20th biggest holding. Trajan Wealth LLC's holdings in UnitedHealth Group were worth $23,369,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in UnitedHealth Group in the 4th quarter worth $26,000. Bayforest Capital Ltd boosted its position in shares of UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares in the last quarter. IAG Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group during the 1st quarter valued at about $42,000. Kapitalo Investimentos Ltda acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $41,000. Finally, Copia Wealth Management acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $42,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 3.7%

Shares of UNH stock traded up $9.22 during trading on Tuesday, reaching $261.59. The company's stock had a trading volume of 12,160,581 shares, compared to its average volume of 18,478,328. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The business has a fifty day moving average price of $289.94 and a 200-day moving average price of $402.24. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The company has a market cap of $237.30 billion, a price-to-earnings ratio of 11.33, a price-to-earnings-growth ratio of 1.63 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same period last year, the company posted $6.80 earnings per share. The business's revenue was up 12.9% compared to the same quarter last year. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a dividend yield of 3.4%. UnitedHealth Group's payout ratio is currently 38.30%.

Insider Buying and Selling

In other UnitedHealth Group news, Director Kristen Gil purchased 3,700 shares of the firm's stock in a transaction that occurred on Thursday, May 15th. The shares were acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the purchase, the director owned 3,818 shares of the company's stock, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the firm's stock in a transaction that occurred on Friday, May 16th. The stock was acquired at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the purchase, the chief executive officer directly owned 679,493 shares of the company's stock, valued at $196,081,295.01. This represents a 14.63% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders purchased 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Robert W. Baird reiterated an "underperform" rating and set a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. JPMorgan Chase & Co. cut their price target on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a report on Wednesday, August 6th. Piper Sandler cut their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. UBS Group reaffirmed a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Finally, Wells Fargo & Company lowered their price target on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and fifteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $366.52.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.